Novo Seeds

Novo Seeds is a capital investment and private equity firm that is interested in biotechnology sectors that deliver healthcare applications. The firm was founded in 2007, in Hallerup, Hovedstaden, Denmark.

The firm is interested in companies that develop drugs for illnesses, molecules that interact with disease-causing modalities, biotechnology, protein interactions, and proprietary platforms. The firm has made a total of nineteen investments, with notable exits including Galecto Biotech and Lysogene. The firm invests during Series B and venture rounds.

The firm is interested in companies that develop drugs for illnesses, molecules that interact with disease-causing modalities, biotechnology, protein interactions, and proprietary platforms. The firm has made a total of nineteen investments, with notable exits including Galecto Biotech and LysogeneLysogene. The firm invests during Series B and venture rounds.